Publications

6-OHDA injections into A8-A9 dopaminergic neurons modelling early stages of Parkinson's disease increase the harmaline-induced tremor in rats. Wacław Kolasiewicz, Katarzyna Kuter, Klemencja Berghauzen, Przemysław Nowak, Gert Schulze, Krystyna Ossowska
Brain research, 10.1016/j.brainres.2012.08.015 S0006-8993(12)01318-2
PMID:22902616
Monday, 24 September 2012
Partial lesion of the dopaminergic innervation of the ventral striatum induces Katarzyna Kuter, Wacław Kolasiewicz, Krystyna Gołembiowska, Anna Dziubina, Gert Schulze, Klemencja Berghauzen, Jadwiga Wardas, Krystyna Ossowska
Pharmacological reports : PR,
PMID:22358086
Thursday, 23 February 2012
Rosiglitazone decreases peroxisome proliferator receptor-γ levels in microglia and inhibits TNF-α production: new evidences on neuroprotection in a progressive Parkinson's disease model. A R Carta, L Frau, A Pisanu, J Wardas, S Spiga, E Carboni
Neuroscience, 10.1016/j.neuroscience.2011.07.046
PMID:21839812
Thursday, 29 September 2011
Lesion of the cerebellar noradrenergic innervation enhances the harmaline-induced tremor in rats. Wacław Kolasiewicz, Katarzyna Kuter, Przemysław Nowak, Agnieszka Pastuszka, Krystyna Ossowska
Cerebellum (London, England), 10.1007/s12311-011-0250-9
PMID:21279489
Tuesday, 14 June 2011
Different effects of intranigral and intrastriatal administration of the proteasome inhibitor lactacystin on typical neurochemical and histological markers of Parkinson's disease in rats. Elżbieta Lorenc-Koci, Tomasz Lenda, Lucyna Antkiewicz-Michaluk, Jadwiga Wardas, Helena Domin, Maria Smiałowska, Jolanta Konieczny
Neurochemistry international, 10.1016/j.neuint.2011.03.013
PMID:21419185
Wednesday, 16 March 2011
Neuroprotective and anti-inflammatory effects of the adenosine A(2A) receptor antagonist ST1535 in a MPTP mouse model of Parkinson's disease. Lucia Frau, Franco Borsini, Jadwiga Wardas, Amit S Khairnar, Nicoletta Schintu, Micaela Morelli
Synapse (New York, N.Y.), 10.1002/syn.20833
PMID:20665698
Thursday, 30 December 2010
Inactivation of neuronal forebrain A receptors protects dopaminergic neurons in a mouse model of Parkinson's disease. Anna R Carta, Anil Kachroo, Nicoletta Schintu, Kui Xu, Michael A Schwarzschild, Jadwiga Wardas, Micaela Morelli
Journal of neurochemistry, 10.1111/j.1471-4159.2009.06425.x
PMID:19817968
Monday, 21 December 2009
Treatment with 1,2,3,4,-tetrahydroisoquinoline affects glutamate release in the striatum but not the binding of [3H]MK-801 to NMDA receptors in the dopaminergic structures of the rat brain. Elzbieta Lorenc-Koci, Krystyna Gołembiowska, Małgorzata Pietraszek, Jadwiga Wardas
Pharmacological reports : PR,
PMID:19904002
Wednesday, 11 November 2009
Impulse control disorders and dopamine dysregulation syndrome associated with dopamine agonist therapy in Parkinson's disease. Sandro Fenu, Jadwiga Wardas, Micaela Morelli
Behavioural pharmacology, 10.1097/FBP.0b013e32833109a0
PMID:19724195
Thursday, 10 September 2009
Role of the metabotropic glutamate receptor subtype 1 in the harmaline-induced tremor in rats. Wacław Kolasiewicz, Katarzyna Kuter, Jadwiga Wardas, Krystyna Ossowska
Journal of neural transmission (Vienna, Austria : 1996), 10.1007/s00702-009-0254-5
PMID:19551466
Wednesday, 26 August 2009